Neratinib
Drug information
- CovInDB Drug
- DB11828
- Name
- Neratinib
- Molecular Formula
- C30H29ClN6O3
- Molecular Weight
- 556.2 g/mol
- Description
- Neratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. Approval was granted to Puma Biotechnology Inc. for the tradename Nerlynx. Neratinib is currently under investigation for use in many other forms of cancer.
- Status
- approved, investigational
- Structure
-
- Indication
- For use as an extended adjuvant treatment in adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.
- Mechanism of action
-
Neratinib binds to and irreversibly inhibits EGFR, HER2, and HER4. This prevents auotphoshorylation of tyrosine residues on the receptor and reduces oncogenic signalling through the mitogen-activated protein kinase and Akt pathways.
- IUPAC Name
- (E)-N-[4-[3-chloro-4-(2-pyridylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide
- InChI
- InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+
- InChI Key
- JWNPDZNEKVCWMY-VQHVLOKHSA-N
- Canonical SMILES
- CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N
- Reference
- DrugBank
Covalent Inhibition
- Warhead
- Micheal Acceptor
- Target
-
Epidermal growth factor receptor   [ UniProt: P00533 ]
- Site
- CYS-797
- Inhibition Mechanism
-
3D Structure
Calculated Properties
- logP
-
4.72
Computed by ALOGPS
- logS
-
-4.92
Computed by ALOGPS
- Heavy Atom Count
-
40
Computed by RDKit
- Ring Count
-
4
Computed by RDKit
- Hydrogen Bond Acceptor Count
-
8
Computed by RDKit
- Hydrogen Bond Donor Count
-
2
Computed by RDKit
- Rotatable Bond Count
-
11
Computed by RDKit
- Topological Polar Surface Area
-
112.4 Å2
Computed by RDKit
Similar compounds in Virtual Screening library
Similar Natural compounds
No similar natural compounds found for this drug.